CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows provided by operating activities:
Net loss	$ (22,255)	$ (61,257)	$ (51,157)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	2,193	1,751	1,152
Amortization of intangible assets	54,711	58,196	58,429
Amortization of deferred contract costs	8,816	4,793	1,671
Equity-based compensation	36,434	9,957	1,747
Noncash paid in-kind interest expense	0	0	7,371
Amortization of debt issuance costs	702	1,698	2,061
Provision for doubtful accounts receivable	1,325	632	895
Loss in extinguishment of debt	0	9,843	0
Non-cash restructuring charges related to office leases	1,023	0	0
Tax receivable agreement remeasurement	(9,374)	0	0
Changes in fair value of contingent consideration	1,250	3,764	2,636
Deferred income taxes	(17,293)	682	0
Changes in operating assets and liabilities:
Accounts receivable	(13,222)	(10,726)	(8,294)
Prepaid expenses and other current assets	(127)	(3,729)	(709)
Deferred contract costs	(15,252)	(14,441)	(7,685)
Contingent consideration	(6,400)	0	0
Accounts payable, accrued expenses and other liabilities	358	1,088	2,996
Deferred revenue	12,690	22,961	12,104
Net cash provided by operating activities	35,579	25,212	23,217
Cash flows (used in) provided by investing activities:
Purchases of property, equipment and other assets	(8,326)	(6,731)	(1,395)
Purchases of short-term investments	(337,961)	0	0
Maturities of short-term investments	153,680	0	0
Cash paid for acquisitions and investments, net of cash acquired	(56,296)	(40,000)	(22,467)
Net cash used in investing activities	(248,903)	(46,731)	(23,862)
Cash flows (used in) provided by financing activities:
Proceeds from Term Loan	0	275,000	0
Proceeds from delayed draw term loan	0	0	18,000
Proceeds from revolving credit facility	0	0	25,000
Repayments of term loans and delayed draw term loan	(6,875)	(474,460)	(4,545)
Taxes paid related to net share settlement of equity awards	(4,116)	0	0
Repayments on revolving credit facility	0	0	(25,000)
Payment of contingent consideration	(1,100)	(1,500)	0
Payment of debt issuance costs	0	(3,511)	(225)
Proceeds from equity offering, net of underwriting discounts	0	834,952	0
Repurchase of outstanding equity / Definitive OpCo units	0	(231,772)	0
Payments of equity offering issuance costs	(1,734)	(11,709)	0
Members contributions	0	5,500	6,365
Members distributions	(12,871)	(8,128)	(2,940)
Net cash (used in) provided by financing activities	(26,696)	384,372	16,655
Net (decrease) increase in cash and cash equivalents	(240,020)	362,853	16,010
Effect of exchange rate changes on cash and cash equivalents	(544)	(129)	146
Cash and cash equivalents, beginning of year	387,498	24,774	8,618
Cash and cash equivalents, end of year	146,934	387,498	24,774
Supplemental cash flow disclosures:
Interest	10,443	29,569	25,958
Income taxes	0	13	0
Acquisitions
Net assets acquired, net of cash acquired	97,296	0	43,571
Initial cash investment in prior year	(40,000)	0	0
Capital contribution	0	0	(25,439)
Contingent consideration	(1,000)	0	(2,600)
Consideration paid to former members included in accrued expenses	0	0	6,935
Net cash paid for acquisitions	56,296	0	22,467
Supplemental disclosures of non-cash investing activities:
Capital expenditures included in accounts payable and accrued expenses and other current liabilities	1,166	654	3,389
Supplemental disclosures of non-cash financing activities:
Unpaid equity offering costs included in accrued expenses	$ 0	$ 1,299	$ 0